« Back
Home /
Doxifluridine

Doxifluridine

Manufacturer	MedChem Express
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Gastric Cancer
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	1 g
Item no.	HY-B0021-1g
Targets	Nucleoside Antimetabolite/Analog
CASRN	3094-09-5
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Doxifluridine has anticancer activity. Doxifluidine is a 5-FU prodrug. Doxifluridine is a thymidine synthase inhibitor. Doxifluridine can enhance tumor inhibition by synergizing with a variety of drugs[1][2][3].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-programmed cell death
MolecularWeight	246.19
Clinical_Information	Launched
Manufacturers Research_Area	Cancer
Solubility	DMF : 100 mg/mL (ultrasonic)\|DMSO : ≥ 100 mg/mL\|H2O : 20 mg/mL (ultrasonic)
Manufacturers Target	Thymidylate Synthase
Pathway	Apoptosis
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-B0021-1g-safety-datasheet.pdf